# A Study of Treatment Patterns and Clinical Outcomes in First Line Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (1L R/M SCCHN) Participants in Europe

> **NCT05123950** · — · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 304 (actual)

## Conditions studied

- Squamous Cell Carcinoma of the Head and Neck

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05123950
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-01
- **Primary completion:** 2021-03-19
- **Final completion:** 2021-03-19
- **Target enrollment:** 304 (ACTUAL)
- **Last updated:** 2021-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05123950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05123950, "A Study of Treatment Patterns and Clinical Outcomes in First Line Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (1L R/M SCCHN) Participants in Europe". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05123950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*